Edap Tms (NASDAQ:EDAP) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a report released on Wednesday. The firm set a "hold" rating on the medical equipment provider's stock.

A number of other analysts also recently issued reports on the company. Jefferies Financial Group reissued a "hold" rating and issued a $2.00 target price (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. HC Wainwright restated a "buy" rating and issued a $19.00 price objective on shares of Edap Tms in a research note on Friday, March 28th. Finally, Piper Sandler reduced their target price on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a research note on Friday, March 28th.

Edap Tms Stock Performance

Shares of Edap Tms stock opened at $2.15 on Wednesday. The stock has a fifty day moving average price of $1.98 and a 200-day moving average price of $2.28. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The firm has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.13. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.30.

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. Equities research analysts anticipate that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently bought and sold shares of the company. Illumine Investment Management LLC bought a new position in shares of Edap Tms in the fourth quarter worth $50,000. Jane Street Group LLC boosted its stake in Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after buying an additional 73,361 shares during the period. Millennium Management LLC increased its stake in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 33,558 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock valued at $108,000 after acquiring an additional 25,650 shares during the last quarter. Finally, Cetera Investment Advisers increased its position in shares of Edap Tms by 33.9% in the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after purchasing an additional 19,000 shares during the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.